942 Should second TUR be performed in the first 2–6 weeks after the initial TUR necessarily in high risk non-muscle invasive bladder cancer patients receiving maintanance BCG? Multicenter trial of Turkish Society of Urooncology

Second Tur ◽

Muscle Invasive ◽

Turkish Society

Long-Term Outcomes and Costs Among BCG-treated High-Risk Non-Muscle Invasive Bladder Cancer Patients in an Equal Access Setting

Urologic Oncology Seminars and Original Investigations ◽

10.1016/j.urolonc.2020.10.041 ◽

2020 ◽

Vol 38 (12) ◽

pp. 902

Author(s):

SB Williams ◽

LE Howard ◽

ML Foster ◽

Z Klaassen ◽

H Li ◽

...

Keyword(s):

Bladder Cancer ◽

High Risk ◽

Cancer Patients ◽

Equal Access ◽

Invasive Bladder Cancer ◽

Long Term Outcomes ◽

PCN233 TREATMENT PATTERNS IN HIGH-RISK, BACILLE CALMETTE-GUÉRIN UNRESPONSIVE NON-MUSCLE INVASIVE BLADDER CANCER PATIENTS: A SYSTEMATIC LITERATURE REVIEW

Value in Health ◽

10.1016/j.jval.2020.04.1704 ◽

2020 ◽

Vol 23 ◽

pp. S64

Author(s):

E. Broughton ◽

D. Chun ◽

K. Gooden ◽

K. Hofer ◽

M.S. Fazeli

Keyword(s):

Bladder Cancer ◽

High Risk ◽

Literature Review ◽

Cancer Patients ◽

Systematic Literature Review ◽

Treatment Patterns ◽

Invasive Bladder Cancer ◽

Bacille Calmette Guerin ◽

PD19-07 ONE-YEAR FOLLOW-UP RESULTS AFTER SEQUENTIAL INTRAVESICAL BACILLUS CALMETTE-GUÉRIN AND DEVICE-ASSISTED CHEMO-HYPERTHERMIA (MITOMYCIN C DELIVERED BY THE COMBAT BRS SYSTEM) FOR HIGH RISK NON-MUSCLE INVASIVE BLADDER CANCER PATIENTS...A BACILLUS CALMETTE-GUÉRIN-SPARING STRATEGY

The Journal of Urology ◽

10.1016/j.juro.2017.02.880 ◽

2017 ◽

Vol 197 (4S) ◽

Cited By ~ 1

Author(s):

TR Leyshon Griffiths ◽

William JF Green ◽

Peter T Grice ◽

Jonathan C Goddard ◽

Roger C Kockelbergh

Keyword(s):

Bladder Cancer ◽

High Risk ◽

Cancer Patients ◽

Mitomycin C ◽

Invasive Bladder Cancer ◽

Bacillus Calmette Guerin ◽

Muscle Invasive ◽

One Year

Is it safe to replace ReTUR in high grade T1 non-muscle invasive bladder cancer patients with urine cytology and in-office cystoscopy? Preliminary results from an ongoing prospective multicenter trial

European Urology ◽

10.1016/s0302-2838(21)01138-6 ◽

2021 ◽

Vol 79 ◽

pp. S1053

Author(s):

R. Contieri ◽

R. Hurle ◽

A. Saita ◽

P. Casale ◽

G. Lughezzani ◽

...

Keyword(s):

Bladder Cancer ◽

Cancer Patients ◽

Multicenter Trial ◽

Urine Cytology ◽

Invasive Bladder Cancer ◽

High Grade ◽

Preliminary Results ◽

Muscle Invasive ◽

Prospective Multicenter Trial

650 WHO ARE AT HIGH-RISK FOR CANCER DEATH AMONG MUSCLE-INVASIVE BLADDER CANCER PATIENTS TREATED WITH CHEMORADIATION-BASED BLADDER- SPARING PROTOCOLS?

European Urology Supplements ◽

10.1016/s1569-9056(11)60639-8 ◽

2011 ◽

Vol 10 (2) ◽

pp. 210

Author(s):

F. Koga ◽

M. Yokoyama ◽

J. Ishioka ◽

N. Numao ◽

K. Saito ◽

...

Keyword(s):

Bladder Cancer ◽

High Risk ◽

Cancer Patients ◽

Invasive Bladder Cancer ◽

Cancer Death ◽

Muscle Invasive ◽

Bladder Sparing

Effect of Age on Outcome of High-Risk Non-Muscle-Invasive Bladder Cancer Patients Treated with Second Transurethral Resection and Maintenance Bacillus Calmette-Guerin Therapy

Journal of Urological Surgery ◽

10.4274/jus.2016.1009 ◽

2016 ◽

Vol 3 (3) ◽

pp. 74-79

Author(s):

Sümer Baltacı ◽

Murat Bozlu ◽

Asıf Yıldırım ◽

Mehmet İlker Gökçe ◽

İlker Tinay ◽

...

Keyword(s):

Bladder Cancer ◽

High Risk ◽

Cancer Patients ◽

Transurethral Resection ◽

Invasive Bladder Cancer ◽

Bacillus Calmette Guerin ◽

Muscle Invasive ◽

Effect Of Age

Outcomes of BCG Induction in High-Risk Non-Muscle-Invasive Bladder Cancer Patients (NMIBC): A Retrospective Cohort Study

Cureus ◽

10.7759/cureus.957 ◽

2017 ◽

Author(s):

Muhammad T Pirzada ◽

Rashid Ghauri ◽

Monis J Ahmed ◽

Muhammad F Shah ◽

Irfan ul Islam Nasir ◽

...

Keyword(s):

Bladder Cancer ◽

Cohort Study ◽

High Risk ◽

Cancer Patients ◽

Retrospective Cohort Study ◽

Retrospective Cohort ◽

Invasive Bladder Cancer ◽

When the conservative treatment in high-risk non-muscle invasive bladder cancer patients should be abandoned

Urologia Journal ◽

10.5301/ru.2013.10866 ◽

2013 ◽

Vol 80 (Suppl. 21) ◽

pp. 48-52 ◽

Cited By ~ 1

Author(s):

Renzo Colombo ◽

Carmen Maccagnano ◽

Lorenzo Rocchini ◽

Federico Pellucchi

Keyword(s):

Bladder Cancer ◽

High Risk ◽

Conservative Treatment ◽

Cancer Patients ◽

Invasive Bladder Cancer ◽

When the Conservative Treatment in High-Risk Non-Muscle Invasive Bladder Cancer Patients should be Abandoned

Urologia Journal ◽

10.5301/ru.2013.108566 ◽

2013 ◽

Vol 80 (21_suppl) ◽

pp. 48-52

Author(s):

Renzo Colombo ◽

Carmen Maccagnano ◽

Lorenzo Rocchini ◽

Federico Pellucchi

Keyword(s):

Bladder Cancer ◽

High Risk ◽

Conservative Treatment ◽

Cancer Patients ◽

Invasive Bladder Cancer ◽

Reply to Charalampos Fragkoulis, Georgios Papadopoulos, and Konstantinos Ntoumas’s Letter to the Editor re: Francesco Del Giudice, Giovanni Barchetti, Ettore De Berardinis, et al. Prospective Assessment of Vesical Imaging Reporting and Data System (VI-RADS) and its Clinical Impact on the Management of High-risk Non–muscle-invasive Bladder Cancer Patients Candidate for Repeated Transurethral Resection. Eur Urol 2020;77:101–9

European Urology ◽

10.1016/j.eururo.2020.01.020 ◽

2020 ◽

Vol 77 (4) ◽

pp. e94-e95 ◽

Cited By ~ 1

Author(s):

Francesco Del Giudice ◽

James W.F. Catto ◽

Valeria Panebianco

Keyword(s):

Bladder Cancer ◽

High Risk ◽

Cancer Patients ◽

Transurethral Resection ◽

Clinical Impact ◽

Data System ◽

Invasive Bladder Cancer ◽

Prospective Assessment ◽